Amedeo Smart

Free Medical Literature Service


 

Amedeo

Malignant Lymphoma

  Free Subscription

28.09.2026

1 Bone Marrow Transplant
1 Br J Haematol
1 Cancer Lett
7 Haematologica
1 Int J Radiat Oncol Biol Phys
1 Leukemia



    Bone Marrow Transplant

  1. ARVANITIS I, Maschio C, Panaretos D, Osorio Zuluaga J, et al
    Reduced-intensity T-replete allogeneic stem cell transplantation provides long-term survival in relapsed angioimmunoblastic T-cell lymphoma post-autologous transplant in patients over the age of 50.
    Bone Marrow Transplant. 2026 Sep 23. doi: 10.1038/s41409-026-03037.
    >> Share


    Br J Haematol

  2. YAGUCHI A, Fujimura J
    Generalised FDG-avid lymphadenopathy in Kikuchi-Fujimoto disease mimicking malignant lymphoma.
    Br J Haematol. 2026 Sep 25. doi: 10.1111/bjh.70827.
    >> Share


    Cancer Lett

  3. CHI Z, Xu N, Sun Y, Zhang B, et al
    CD20 targeted nanomedicine enhances anti-tumor immunity in diffuse large B-cell lymphoma by activating cGAS/STING pathway.
    Cancer Lett. 2026 Sep 19:218850. doi: 10.1016/j.canlet.2026.218850.
    >> Share


    Haematologica

  4. EVERARD KR, Turingan MA, Tam I, Sakhdari A, et al
    DLBCL2IDCS: transdifferentiation of diffuse large B-cell lymphoma to interdigitating dendritic cell sarcoma.
    Haematologica. 2026 Sep 24. doi: 10.3324/haematol.2026.301316.
    >> Share

  5. WANG J, Yi D, Gao Y, Yang F, et al
    Rituximab maintenance following frontline bendamustine-rituximab in mantle cell lymphoma: a systematic review and meta-analysis.
    Haematologica. 2026 Sep 24. doi: 10.3324/haematol.2026.301413.
    >> Share

  6. NISHIMURA Y, Maiocco J, Janda G, Nedved A, et al
    Clinical outcomes and safety of the immune checkpoint inhibitor rechallenge in Hodgkin lymphoma: an off-trial analysis.
    Haematologica. 2026 Sep 24. doi: 10.3324/haematol.2026.301311.
    >> Share

  7. DAY JR, Larson MC, Casulo C, Durani U, et al
    Patterns of care, outcomes, and prognostics for transformed follicular lymphoma in the rituximab era.
    Haematologica. 2026 Sep 24. doi: 10.3324/haematol.2026.300768.
    >> Share

  8. VINCENZI A, Picardi M
    Who needs bleomycin in classic Hodgkin lymphoma? Comment on: "Bleomycin omission in limited-stage classic Hodgkin lymphoma with negative PET scan after two cycles of ABVD".
    Haematologica. 2026 Sep 24. doi: 10.3324/haematol.2026.301946.
    >> Share

  9. IANNITTO E, Donzelli L, Di Rocco A, Zinzani PL, et al
    Primary mediastinal B-cell lymphoma: a nationwide real-life retrospective study of first-line treatment approaches in Italy.
    Haematologica. 2026 Sep 24. doi: 10.3324/haematol.2026.301124.
    >> Share

  10. GUIDETTI A, Dogliotti I, Chiappella A, Iannitto E, et al
    Different treatment eras for relapsed and refractory primary mediastinal B-cell lymphoma patients: accessibility to CAR T cells is associated with a better prognosis in a pooled analysis of the REPRIME-FIL and the CART-SIE studies.
    Haematologica. 2026 Sep 24. doi: 10.3324/haematol.2026.300977.
    >> Share


    Int J Radiat Oncol Biol Phys

  11. ABAI S, Danzer MF, Assaf C, Mula-Hussain L, et al
    Reduced-Dose Total Skin Electron Beam Radiation Therapy in Mycosis Fungoides and Sezary Syndrome: Systematic Review and Meta-Analysis.
    Int J Radiat Oncol Biol Phys. 2026;126:782-793.
    >> Share


    Leukemia

  12. YANG X, Peng J, Mao X, Zhang L, et al
    Endoplasmic reticulum stress promotes leukemic plasmacytoid dendritic cell differentiation skewing and immune suppression in acute myeloid leukemia.
    Leukemia. 2026 Aug 3. doi: 10.1038/s41375-026-03080.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016